Keith Valentine Leaving NuVasive; Pat Miles Taking Over

NuVasive, Inc. has announced that its Chief Operating Officer (COO) Keith Valentine, will step down leave the company as of April 30, 2015. Pat Miles, NuVasive’s current president of Global Products and Services, will assume an expanded role as President and COO.

Valentine told OTW, “Helping to grow NuVasive from no revenues to a company that is quickly approaching $1 billion in revenues has been an extraordinary experience and a privilege to serve so many dedicated shareowners committed to changing spine surgery, and departing the company is a personal decision for me. The challenging and dynamic nature of start-up businesses has a tremendous appeal to me and—with the great learning opportunity and dynamic teams I’ve been able to experience at Nuvasive—I’m now looking to fulfill long-held professional aspirations that will focus on that start-up mentality with the goal of leading a company through the evolution of its growth.”

“The most important lesson I’ve learned at NuVasive is the value of a strong and contagious corporate culture. The company’s shareowners are completely invested in the company’s success and it is key competitive advantage at NuVasive [that] continues to drive the most innovative and disruptive procedural solutions in spine.”

Pat Miles will continue to be responsible for leadership and management of global products and services. In addition, he will take on NuVasive’s operational duties, including customer fulfillment, manufacturing, supply chain management and quality engineering.

Miles told OTW, “Our ability to adapt and transform to the rapidly shifting and dynamic markets in which we participate is essential to our success. My first priority will be to ensure that our operating structure matches our growth strategy as we continue to rapidly scale the business. The successful integration of global products and services function with operational activities will fuel our market share-taking strategy to be executed over the next five years, positioning NuVasive competitively as an innovator and disruptor in spine.”

The January 12, 2015 news release indicated that Matt Link, currently executive vice president of U.S. Sales, will become president of U.S. Sales and Services and will lead an expanded team. The company will be integrating and aligning all “U.S. field personnel to form a combined sales and services organization. This will include the consolidation of the company’s field sales, clinical associates, IMI [Impulse Monitoring Inc.] neurophysiologists and monitoring contracting.”